Don’t have an account?
New to Moneycontrol - Sign up now
Its easy and FREE!
OR connect with
latest news (see all)
Sat, Mar 31, 2012 at 19:25
Ranbaxy Pharmaceuticals Canada Inc., a wholly owned subsidiary of Ranbaxy Labs, has received approval from Health Canada to manufacture and market RAN - Rosuvastatin tablets in Canada, which is used for lowering cholesterol
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.